home / stock / avhhl / avhhl news

AVHHL News and Press, Avita Therapeutics From 07/20/23

Stock Information
Company Name: Avita Therapeutics
Stock Symbol: AVHHL
Market: OTC
Website: avitamedical.com
Menu
AVHHL AVHHL Quote AVHHL Short AVHHL News AVHHL Articles AVHHL Message Board
Get AVHHL Alerts

News, Short Squeeze, Breakout and More Instantly...
AVHHL - AVITA Medical to Announce Second Quarter 2023 Financial Results

VALENCIA, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, announced today that it will report its...
AVHHL - AVITA Medical Submits FDA PMA Supplement for RECELL GO

VALENCIA, Calif., June 29, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today announced its submission of a pre...

AVHHL - AVITA Medical Rejoins the Russell 3000 Index

VALENCIA, Calif., and MELBOURNE, Australia, June 26, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today announc...

AVHHL - AVITA Medical Announces FDA Approval of RECELL for Skin Repigmentation in Vitiligo Patients

VALENCIA, Calif. and MELBOURNE, Australia, June 16, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today announce...
AVHHL - AVITA Medical Announces Appointment of David O'Toole as Chief Financial Officer

VALENCIA, Calif. and MELBOURNE, Australia, June 15, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today announce...

AVHHL - AVITA Medical Announces FDA Approval of RECELL for Treatment of Full-Thickness Skin Defects

VALENCIA, Calif. and MELBOURNE, Australia, June 07, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today announce...

AVHHL - AVITA Medical, Inc. (RCEL) Q1 2023 Earnings Call Transcript

2023-05-11 22:08:08 ET AVITA Medical, Inc. (RCEL) Q1 2023 Results Conference Call May 11, 2023 04:30 PM ET Company Participants Jessica Ekeberg - Investor Relations James Corbett - Chief Executive Officer Sean Ekins - Acting Chief Financial Officer Conferen...
AVHHL - AVITA Medical Reports First Quarter Financial Results and Affirms Full Year Guidance

VALENCIA, Calif. and MELBOURNE, Australia, May 11, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “ Company ”), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies f...

AVHHL - AVITA Medical to Announce First Quarter 2023 Financial Results

VALENCIA, Calif. and MELBOURNE, Australia, April 20, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, announced tod...

AVHHL - AVITA Medical Announces Update to Automation Device

VALENCIA, Calif. and MELBOURNE, Australia, April 13, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, announced tod...
Previous 10 Next 10